BR112017006420A2 - derivados de ácido borônico - Google Patents
derivados de ácido borônicoInfo
- Publication number
- BR112017006420A2 BR112017006420A2 BR112017006420A BR112017006420A BR112017006420A2 BR 112017006420 A2 BR112017006420 A2 BR 112017006420A2 BR 112017006420 A BR112017006420 A BR 112017006420A BR 112017006420 A BR112017006420 A BR 112017006420A BR 112017006420 A2 BR112017006420 A2 BR 112017006420A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid derivatives
- boronic acid
- anomaly
- employed
- compounds
- Prior art date
Links
- 150000001642 boronic acid derivatives Chemical class 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14003392 | 2014-10-01 | ||
| PCT/EP2015/002008 WO2016050359A1 (en) | 2014-10-01 | 2015-10-01 | Boronic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017006420A2 true BR112017006420A2 (pt) | 2017-12-19 |
Family
ID=51690789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017006420A BR112017006420A2 (pt) | 2014-10-01 | 2015-10-01 | derivados de ácido borônico |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10294246B2 (enExample) |
| EP (1) | EP3201207B1 (enExample) |
| JP (1) | JP6835711B2 (enExample) |
| KR (1) | KR102450583B1 (enExample) |
| CN (1) | CN107001390B (enExample) |
| AU (1) | AU2015327346B2 (enExample) |
| BR (1) | BR112017006420A2 (enExample) |
| CA (1) | CA2963205A1 (enExample) |
| ES (1) | ES2873000T3 (enExample) |
| IL (1) | IL251301B (enExample) |
| MX (1) | MX370336B (enExample) |
| RU (1) | RU2017115188A (enExample) |
| SG (1) | SG11201702623TA (enExample) |
| WO (1) | WO2016050359A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015327411B2 (en) | 2014-10-01 | 2020-01-02 | Merck Patent Gmbh | Boronic acid derivatives |
| CA2963198A1 (en) | 2014-10-01 | 2016-04-07 | Merck Patent Gmbh | Boronic acid derivatives |
| JP6662865B2 (ja) | 2014-10-01 | 2020-03-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ボロン酸誘導体 |
| WO2019038250A1 (en) | 2017-08-24 | 2019-02-28 | Merck Patent Gmbh | Boronic acid derivatives |
| CN112469480A (zh) * | 2018-07-26 | 2021-03-09 | 默克专利股份公司 | 硼酸衍生物 |
| CN113135943A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| CN113135944A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| US20250340577A1 (en) * | 2021-03-02 | 2025-11-06 | Case Western Reserve University | Beta-lactomase inhibitors and uses thereof |
| WO2022243155A1 (en) * | 2021-05-19 | 2022-11-24 | Syngenta Crop Protection Ag | Weed control method |
| IL310390A (en) | 2021-07-29 | 2024-03-01 | Merck Patent Gmbh | Crystalline forms of [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7- oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, adducts thereof, and processes to obtain |
| KR20240090392A (ko) * | 2021-10-14 | 2024-06-21 | 쇼우야오 홀딩스 (베이징) 코., 엘티디. | 보론산 유도체 |
| WO2023232830A1 (en) | 2022-06-02 | 2023-12-07 | Merck Patent Gmbh | Boronic acid adducts |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| EP1196436A2 (en) * | 1999-07-07 | 2002-04-17 | Bristol-Myers Squibb Pharma Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
| US7271186B1 (en) | 2002-12-09 | 2007-09-18 | Northwestern University | Nanomolar β-lactamase inhibitors |
| EA201000774A1 (ru) * | 2007-11-13 | 2010-12-30 | Новартис Интернэшнл Фармасьютикл Лтд. | Ингибиторы бета-лактамазы |
| AR075090A1 (es) * | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
| SG10201605152SA (en) * | 2011-12-22 | 2016-08-30 | Ares Trading Sa | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
| AU2015327411B2 (en) | 2014-10-01 | 2020-01-02 | Merck Patent Gmbh | Boronic acid derivatives |
| CA2963198A1 (en) | 2014-10-01 | 2016-04-07 | Merck Patent Gmbh | Boronic acid derivatives |
| JP6662865B2 (ja) | 2014-10-01 | 2020-03-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ボロン酸誘導体 |
-
2015
- 2015-10-01 SG SG11201702623TA patent/SG11201702623TA/en unknown
- 2015-10-01 CN CN201580053425.1A patent/CN107001390B/zh not_active Expired - Fee Related
- 2015-10-01 EP EP15780765.2A patent/EP3201207B1/en active Active
- 2015-10-01 JP JP2017518100A patent/JP6835711B2/ja not_active Expired - Fee Related
- 2015-10-01 CA CA2963205A patent/CA2963205A1/en active Pending
- 2015-10-01 WO PCT/EP2015/002008 patent/WO2016050359A1/en not_active Ceased
- 2015-10-01 ES ES15780765T patent/ES2873000T3/es active Active
- 2015-10-01 RU RU2017115188A patent/RU2017115188A/ru not_active Application Discontinuation
- 2015-10-01 MX MX2017004046A patent/MX370336B/es active IP Right Grant
- 2015-10-01 KR KR1020177011643A patent/KR102450583B1/ko active Active
- 2015-10-01 BR BR112017006420A patent/BR112017006420A2/pt active Search and Examination
- 2015-10-01 AU AU2015327346A patent/AU2015327346B2/en not_active Ceased
- 2015-10-01 US US15/516,424 patent/US10294246B2/en active Active
-
2017
- 2017-03-21 IL IL251301A patent/IL251301B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017536335A (ja) | 2017-12-07 |
| MX2017004046A (es) | 2017-06-19 |
| CN107001390B (zh) | 2020-11-27 |
| SG11201702623TA (en) | 2017-04-27 |
| US10294246B2 (en) | 2019-05-21 |
| CN107001390A (zh) | 2017-08-01 |
| MX370336B (es) | 2019-12-10 |
| WO2016050359A1 (en) | 2016-04-07 |
| JP6835711B2 (ja) | 2021-02-24 |
| IL251301B (en) | 2022-02-01 |
| AU2015327346A1 (en) | 2017-05-18 |
| RU2017115188A (ru) | 2018-11-06 |
| EP3201207B1 (en) | 2021-02-24 |
| ES2873000T3 (es) | 2021-11-03 |
| AU2015327346B2 (en) | 2019-12-05 |
| RU2017115188A3 (enExample) | 2019-03-29 |
| KR20170062517A (ko) | 2017-06-07 |
| KR102450583B1 (ko) | 2022-10-04 |
| IL251301A0 (en) | 2017-05-29 |
| US20180105539A1 (en) | 2018-04-19 |
| EP3201207A1 (en) | 2017-08-09 |
| CA2963205A1 (en) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017006420A2 (pt) | derivados de ácido borônico | |
| CY1122886T1 (el) | Αναστολεις βρωμοεπικρατειων | |
| MX372823B (es) | Derivados de ácido borónico. | |
| BR112017006368A2 (pt) | derivados de ácido borônico | |
| EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
| EA201692079A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| BR112017006349A2 (pt) | derivados de ácido borônico | |
| EA201691594A1 (ru) | Циклопропиламины в качестве ингибиторов lsd1 | |
| MX377273B (es) | Ciclopropilamina como inhibidor de la desmetilasa 1 específica de lisinas (lsd1). | |
| EA201692203A1 (ru) | Соединения, ингибирующие tank-связывающую киназу | |
| MX377916B (es) | Compuestos 4-amino-imidazoquinolina. | |
| EA201891344A1 (ru) | Новые агонисты рецептора апелина и способы применения | |
| DK3119762T3 (da) | Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft | |
| EA201692513A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| HUE050155T2 (hu) | 1-tetrahidropiranilkarbonil-2,3-dihidro-1H-indol vegyületek rák kezelésére | |
| MX381487B (es) | Ciertos inhibidores de la proteina quinasa. | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| EA201790085A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
| EA201790395A1 (ru) | Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы | |
| EA201790082A1 (ru) | Ингибиторы лизин-специфической демитилазы-1 | |
| BR112017013568A2 (pt) | compostos bicíclicos fundidos para o tratamento de doenças | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| MX2017001352A (es) | Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2). | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| MA39824A (fr) | Composés azole amido-substitués |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |